Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2109619rdf:typepubmed:Citationlld:pubmed
pubmed-article:2109619lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:2109619lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:2109619lifeskim:mentionsumls-concept:C0037868lld:lifeskim
pubmed-article:2109619lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:2109619lifeskim:mentionsumls-concept:C0205148lld:lifeskim
pubmed-article:2109619lifeskim:mentionsumls-concept:C1152102lld:lifeskim
pubmed-article:2109619lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2109619pubmed:issue4lld:pubmed
pubmed-article:2109619pubmed:dateCreated1990-5-31lld:pubmed
pubmed-article:2109619pubmed:abstractTextOne of the mouse sperm surface binding sites for zona pellucida ligands exhibits galactosyltransferase (GT) enzyme activity. The present study was undertaken to ascertain whether the GT site behaves as a noncatalytic binding site in its physiological capacity, with no glycosylation of zona ligands, or whether glycosylation of zona ligands is an integral part of sperm-zona binding. The effects of Mn2+, the obligatory cation for GT catalysis, on enzyme activity and sperm-zona binding were examined. With uridine-5'-diphosphogalactose (UDPgal) as galactose donor, and N-acetylglucosamine (GlcNAc) as galactose acceptor, increasing concentrations of Mn2+ in the range of 0.1-10 mM increased GT enzyme activity, with half-maximal activation at 0.65 mM Mn2+ (Vmax = 20 pmol/hr/10(6) cells). In the presence of 0-2 mM Mn2+, sperm-zona binding was inhibited in a concentration-dependent manner; 50% inhibition occurred at 1.25 mM Mn2+. At this concentration, GT enzyme activity was at 65% Vmax. To determine the specificity of the GT site for glycoprotein terminal carbohydrate residues, spermatozoa were incubated with, asialo-ovine submaxillary mucin (N-acetylgalactosamine residues), asialo-, -alpha 1-acid glycoprotein (beta 1-4 galactose residues) ovalbumin (Ov; GlcNAc residues), and asialo-agalacto-/alpha 1-acid glycoprotein (AsAgAGP; GlcN-Ac residues). Only Ov and AsAgAGP acted as acceptors for galactose in the enzyme assay and inhibitors in the sperm-zona binding assay. The kinetics of the interaction of AsAgAGP with the GT site were determined: the Km was 3.6 mg/ml, with Vmax of 33 pmol/hr/10(6) cells.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2109619pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109619pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109619pubmed:languageenglld:pubmed
pubmed-article:2109619pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109619pubmed:citationSubsetIMlld:pubmed
pubmed-article:2109619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109619pubmed:statusMEDLINElld:pubmed
pubmed-article:2109619pubmed:monthAprlld:pubmed
pubmed-article:2109619pubmed:issn1040-452Xlld:pubmed
pubmed-article:2109619pubmed:authorpubmed-author:StoreyB TBTlld:pubmed
pubmed-article:2109619pubmed:authorpubmed-author:McGuireE JEJlld:pubmed
pubmed-article:2109619pubmed:authorpubmed-author:BenauD ADAlld:pubmed
pubmed-article:2109619pubmed:issnTypePrintlld:pubmed
pubmed-article:2109619pubmed:volume25lld:pubmed
pubmed-article:2109619pubmed:ownerNLMlld:pubmed
pubmed-article:2109619pubmed:authorsCompleteYlld:pubmed
pubmed-article:2109619pubmed:pagination393-9lld:pubmed
pubmed-article:2109619pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:meshHeadingpubmed-meshheading:2109619-...lld:pubmed
pubmed-article:2109619pubmed:year1990lld:pubmed
pubmed-article:2109619pubmed:articleTitleFurther characterization of the mouse sperm surface zona-binding site with galactosyltransferase activity.lld:pubmed
pubmed-article:2109619pubmed:affiliationDepartment of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia 19104-6080.lld:pubmed
pubmed-article:2109619pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2109619pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2109619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2109619lld:pubmed